Grass pollen allergy vaccine (Circassia)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameGrass pollen allergy vaccine (Circassia)
Drug Alias Name草花粉过敏疫苗 - CircassiaToleroMune GrassGrass-Synthetic Peptide Immuno-Regulatory Epitope
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionT lymphocytes modulatorsImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsHypersensitivityConjunctivitisRhinitis, Allergic, Seasonal +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCircassia Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCircassia Ltd
Active IndicationsN/A
Inactive IndicationsHypersensitivityConjunctivitisRhinitis, Allergic, Seasonal +[5] 

Other Information

ATC CodeN/A
Related LinksN/A